glp-1 receptor agonist and dpp-4 inhibitor combination not recommended DPP4 Inhibitors vs Agonists | June 2021 | Clinical Corner Efficacy of GLP-1 Receptor Agonists

Lets not all just jump on the bandwagon

The US GLP-1 receptor agonistmarket size was valued at USD 30.15 billion in 2025 and is projected to reach USD 33.84 billion in 2026

Hansen L, Deacon CF, Orskov C, and Holst JJ

After some time in the Department of Medical Anatomy at the University of Copenhagen, rskov joined Novo Nordisk in 2007 where she became involved in developing new GLP-1 based drugs

If your insurance does not cover these medications, or you are planning on paying out of pocket and need help covering the cost of your medication, it's worth also checking the manufacturer's website for coupons that may save you money on Ozempic, Wegovy, or Mounjaro